Drugs acting on SUR1 to treat CNS ischemia and trauma
- 26 November 2007
- journal article
- review article
- Published by Elsevier in Current Opinion in Pharmacology
- Vol. 8 (1), 42-49
- https://doi.org/10.1016/j.coph.2007.10.004
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Truncation of Kir6.2 produces ATP-sensitive K+ channels in the absence of the sulphonylurea receptorNature, 1997
- Overlapping distribution of KATP channel‐forming Kir6.2 subunit and the sulfonylurea receptor SUR1 in rodent brainFEBS Letters, 1997
- Promiscuous coupling between the sulphonylurea receptor and inwardly rectifying potassium channelsNature, 1996
- The High-Affinity Sulfonylurea Receptor: Distribution, Glycosylation, Purification, and Immunoprecipitation of Two Forms from Endocrine and Neuroendocrine Cell LinesBiochemistry, 1996
- Update on the Pathophysiology and Pathology of Acute Spinal Cord InjuryBrain Pathology, 1995
- Effect of L-NMMA, cromakalim, and glibenclamide on cerebral blood flow in hypercapnia and hypoxiaAmerican Journal of Physiology-Heart and Circulatory Physiology, 1995
- Effects of pH upon the inhibition by sulphonylurea drugs of ATP-sensitive K+ channels in cardiac muscle.1992
- Chronic exposure to glibenclamide impairs insulin secretion in isolated rat pancreatic isletsJournal of Endocrinological Investigation, 1991
- Photoaffinity labeling and partial purification of the beta cell sulfonylurea receptor using a novel, biologically active glyburide analog.Journal of Biological Chemistry, 1990
- [Studies on the bioavailability of glibenclamide].1972